272 related articles for article (PubMed ID: 12941547)
1. Heterozygosity for MICA5.0/MICA5.1 and HLA-DR3-DQ2/DR4-DQ8 are independent genetic risk factors for latent autoimmune diabetes in adults.
Törn C; Gupta M; Nikitina Zake L; Sanjeevi CB; Landin-Olsson M
Hum Immunol; 2003 Sep; 64(9):902-9. PubMed ID: 12941547
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of TNF microsatellite marker a and HLA-DR-DQ in diabetes mellitus-a study in 609 Swedish subjects.
Törn C; Hillman M; Sanjeevi CB; Landin-Olsson M
Hum Immunol; 2006 Jul; 67(7):527-34. PubMed ID: 16829307
[TBL] [Abstract][Full Text] [Related]
3. Frequency of MICA in all babies in southeast Sweden (ABIS) positive for high-risk HLA-DQ associated with type 1 diabetes.
Gupta M; Ludvigsson J; Sanjeevi CB
Ann N Y Acad Sci; 2004 Dec; 1037():138-44. PubMed ID: 15699508
[TBL] [Abstract][Full Text] [Related]
4. Coxsackie virus B antibodies are increased in HLA DR3-MICA5.1 positive type 1 diabetes patients in the Linköping region of Sweden.
Gupta M; Nikitina-Zake L; Landin-Olsson M; Kockum I; Sanjeevi CB
Hum Immunol; 2003 Sep; 64(9):874-9. PubMed ID: 12941542
[TBL] [Abstract][Full Text] [Related]
5. Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus.
Gambelunghe G; Gerli R; Bocci EB; Del Sindaco P; Ghaderi M; Sanjeevi CB; Bistoni O; Bini V; Falorni A
Rheumatology (Oxford); 2005 Mar; 44(3):287-92. PubMed ID: 15522921
[TBL] [Abstract][Full Text] [Related]
6. Different HLA-DR-DQ and MHC class I chain-related gene A (MICA) genotypes in autoimmune and nonautoimmune gestational diabetes in a Swedish population.
Törn C; Gupta M; Sanjeevi CB; Aberg A; Frid A; Landin-Olsson M
Hum Immunol; 2004 Dec; 65(12):1443-50. PubMed ID: 15603871
[TBL] [Abstract][Full Text] [Related]
7. Homozygosity for premature stop codon of the MHC class I chain-related gene A (MIC-A) is associated with early activation of islet autoimmunity of DR3/4-DQ2/8 high risk DAISY relatives.
Ide A; Babu SR; Robles DT; Wang T; Erlich HA; Bugawan TL; Rewers M; Fain PR; Eisenbarth GS
J Clin Immunol; 2005 Jul; 25(4):303-8. PubMed ID: 16133985
[TBL] [Abstract][Full Text] [Related]
8. Type 1 diabetes in the Spanish population: additional factors to class II HLA-DR3 and -DR4.
Urcelay E; Santiago JL; de la Calle H; Martínez A; Méndez J; Ibarra JM; Maluenda C; Fernández-Arquero M; de la Concha EG
BMC Genomics; 2005 Apr; 6():56. PubMed ID: 15842729
[TBL] [Abstract][Full Text] [Related]
9. Early onset of diabetes in the proband is the major determinant of risk in HLA DR3-DQ2/DR4-DQ8 siblings.
Gillespie KM; Aitken RJ; Wilson I; Williams AJ; Bingley PJ
Diabetes; 2014 Mar; 63(3):1041-7. PubMed ID: 24203724
[TBL] [Abstract][Full Text] [Related]
10. High-risk genotypes HLA-DR3-DQ2/DR3-DQ2 and DR3-DQ2/DR4-DQ8 in co-occurrence of type 1 diabetes and celiac disease.
Smigoc Schweiger D; Mendez A; Kunilo Jamnik S; Bratanic N; Bratina N; Battelino T; Brecelj J; Vidan-Jeras B
Autoimmunity; 2016 Jun; 49(4):240-7. PubMed ID: 27138053
[TBL] [Abstract][Full Text] [Related]
11. HLA associations in type 1 diabetes among patients not carrying high-risk DR3-DQ2 or DR4-DQ8 haplotypes.
Undlien DE; Kockum I; Rønningen KS; Lowe R; Saanjeevi CB; Graham J; Lie BA; Akselsen HE; Lernmark A; Thorsby E
Tissue Antigens; 1999 Dec; 54(6):543-51. PubMed ID: 10674967
[TBL] [Abstract][Full Text] [Related]
12. HLA-DPB1*04:01 Protects Genetically Susceptible Children from Celiac Disease Autoimmunity in the TEDDY Study.
Hadley D; Hagopian W; Liu E; She JX; Simell O; Akolkar B; Ziegler AG; Rewers M; Krischer JP; Chen WM; Onengut-Gumuscu S; Bugawan TL; Rich SS; Erlich H; Agardh D;
Am J Gastroenterol; 2015 Jun; 110(6):915-20. PubMed ID: 26010309
[TBL] [Abstract][Full Text] [Related]
13. Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.
El-Amir MI; El-Feky MA; Laine AP; Härkönen T; El-Badawy O; Eltayeb AA; El-Melegy TT; Kiviniemi M; Knip M; Ilonen J
Diabetes Metab Res Rev; 2015 Mar; 31(3):287-94. PubMed ID: 25256132
[TBL] [Abstract][Full Text] [Related]
14. A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity: the findings of a UK population-based family study.
Kozhakhmetova A; Wyatt RC; Caygill C; Williams C; Long AE; Chandler K; Aitken RJ; Wenzlau JM; Davidson HW; Gillespie KM; Williams AJK
Clin Exp Immunol; 2018 Jun; 192(3):251-258. PubMed ID: 29431870
[TBL] [Abstract][Full Text] [Related]
15. HLA-DQ associations in type 1 autoimmune hepatitis.
Czaja AJ; Santrach PJ; Moore SB
Mayo Clin Proc; 1995 Dec; 70(12):1154-60. PubMed ID: 7490916
[TBL] [Abstract][Full Text] [Related]
16. Co-expression of HLA DR3 and DQ8 results in the development of spontaneous insulitis and loss of tolerance to GAD65 in transgenic mice.
Abraham RS; Kudva YC; Wilson SB; Strominger JL; David CS
Diabetes; 2000 Apr; 49(4):548-54. PubMed ID: 10871191
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetes.
Hannelius U; Beam CA; Ludvigsson J
Diabetologia; 2020 Oct; 63(10):2177-2181. PubMed ID: 32754804
[TBL] [Abstract][Full Text] [Related]
18. Transcomplementation of HLA DQA1-DQB1 in DR3/DR4 and DR3/DR9 heterozygotes and IDDM in Taiwanese families.
Chuang LM; Wu HP; Tsai WY; Lin BJ; Tai TY
Diabetes Care; 1995 Nov; 18(11):1483-6. PubMed ID: 8722074
[TBL] [Abstract][Full Text] [Related]
19. Insulin-dependent diabetes mellitus in non-DR3/non-DR4 subjects.
Dubois-Laforgue D; Timsit J; Djilali-Saiah I; Boitard C; Caillat-Zucman S
Hum Immunol; 1997 Oct; 57(2):104-9. PubMed ID: 9438201
[TBL] [Abstract][Full Text] [Related]
20. Non-transmitted maternal HLA DQ2 or DQ8 alleles and risk of Type I diabetes in offspring: the importance of foetal or post partum exposure to diabetogenic molecules.
Pani MA; Van Autreve J; Van der Auwera BJ; Gorus FK; Badenhoop K
Diabetologia; 2002 Sep; 45(9):1340-3. PubMed ID: 12242468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
